NCT02227706 - The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2014

Primary Completion Date

April 17, 2019

Study Completion Date

May 17, 2019

Conditions

HemorrhageSoft Tissue Bleeding

Interventions

BIOLOGICAL

EVICEL® Fibrin Sealant

EVICEL® is a human plasma-derived fibrin sealant. EVICEL® consists of two components: a concentrate of Human Clottable Protein (referred to as Biological Component 2; BAC2) and a solution of Human Thrombin. No material of animal origin is present in the product

DEVICE

SURGICEL® Absorbable Hemostat

SURGICEL® Absorbable Hemostat (oxidized regenerated cellulose) is a sterile absorbable knitted fabric prepared by the controlled oxidation of regenerated cellulose.

Trial Locations (13)

Unknown

Clinical Investigation Site #31, Brussels

Clinical Investigation Site #42, Hamilton

Clinical Investigation Site #40, Toronto

Clinical Investigation Site #41, Montreal

Clinical Investigation Site #21, Birmingham

Clinical Investigation Site #22, Leeds

Clinical Investigation Site #20, Liverpool

Clinical Investigation Site #23, London

Clinical Investigation Site #26, London

Clinical Investigation Site #30, Newcastle

Clinical Investigation Site #24, Southampton

SE1 7EH

Clinical Investigation Site #27, London

NG7 2UH

Clinical Investigation Site #25, Nottingham

All Listed Sponsors

lead

Ethicon, Inc.

INDUSTRY